Popular search terms:
Search Results
54 results found-
CSL Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.
https://www.cslseqirus.com.au/expertise/influenza/pandemic-response-solutions -
CSL Seqirus is one of the largest influenza vaccine companies in the world, with state-of-the-art manufacturing facilities on three continents. Learn more.
https://www.cslseqirus.com.au/manufacturing/global-manufacturing-network -
CSL Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.
https://www.cslseqirus.com.au/expertise -
CSL Seqirus has today announced that construction of its new state-of-the-art manufacturing facility in Australia has reached its highest point, known as ‘topping out’.
https://www.cslseqirus.com.au/news/csl-seqirus-vaccine-and-antivenom-manufacturing-facility-in-australia-construction-milestone -
Cell-based influenza vaccines demonstrated between 10% and 15% relative vaccine effectiveness across three recent seasons compared to traditional egg-based vaccines in the prevention of test-confirmed influenza, according to a new study presented at ESWI Influenza Conference in Spain.
https://www.cslseqirus.com.au/news/cell-based-flu-vaccines-demonstrate-superior-effectiveness-as-csl-builds-manufacturing-in-melbourne -
Ferinject is now indicated by the Therapeutic Goods Administration (TGA) in Australia for the treatment of iron deficiency anaemia in children.
https://www.cslseqirus.com.au/news/ferinject-ferric-carboxymaltose-approved-for-australian-children-living-with-iron-deficiency-anaemia -
A new survey released ahead of Iron Deficiency Day 2023 (26 November) shows that while many Australians have heard of iron deficiency, a significant majority are unaware of what symptoms they should be looking out for.
https://www.cslseqirus.com.au/news/new-survey-shows-significant-gaps-in-australians-understanding-of-iron-deficiency -
CSL Seqirus, as a member of the CSL group, is bound by CSL's Code of Responsible Business Practice. Access our annual financial and diversity disclosures.
https://www.cslseqirus.com.au/our-company/corporate-responsibility/disclosures -
With summer fast approaching, new research released today on National Venomous Bites and Stings Day reveals that many Australians are missing vital venomous bites and stings first aid knowledge.
https://www.cslseqirus.com.au/news/new-research-reveals-what-australians-arent-prepared-for-this-summer -
Read the latest news from CSL Seqirus, a world leader in developing and producing influenza vaccines.
https://www.cslseqirus.com.au/news/csl-seqirus-private-market-influenza-vaccines-now-available-as--australia-sees-early-rise-flu-cases